Latest News

Sina Nikayin, MD, assistant professor of psychiatry, and Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, are co-authors of a viewpoint in JAMA Psychiatry that explores how expectations influence outcomes of psychedelic drug therapy.

Off-label, unsupervised use of ketamine has skyrocketed since regulatory changes were put in place at the height of the COVID pandemic. Yale psychiatrist Gerard Sanacora, a worldleader in ketamine research and clinical use, discusses some of the risks patients may be taking.

Yale researchers Greg Rhee, PhD; John H. Krystal, MD; Gerard Sanacora, MD, PhD; and Samuel Wilkinson, MD, conducted a meta analysis published in JAMA Psychiatry to determine if ketamine is as effective as electroconvulsive therapy in patients with major depressive episode.

Sina Nikayin, MD, assistant professor of psychiatry, and Robert Ostroff, MD, co-medical director of the Interventional Psychiatry Service at Yale New Haven Psychiatric Hospital, are co-authors of a paper in Journal of the Neurological Sciences that describes interventional psychiatry training at Yale New Haven Psychiatric Hospital.

Before the COVID-19 pandemic hit early last year, the interventional psychiatry service at Yale held regular meetings for team members. But once coronavirus-imposed lockdowns began sweeping the nation, the meetings – like many others – were moved to Zoom. Sina Nikayin, MD, a Fourth-Year Resident and the Chief Resident of Interventional Psychiatry, saw an opportunity to help promote educational session on the topic of interventional psychiatry.

Wherever constant stress lives, so too does its more agitated and debilitating cousin: anxiety. About 31% of Americans will experience an anxiety disorder at some point in their lives. What’s more, anxiety often goes hand-in-hand with depression.